The WSJ reports that Sanofi-Aventis SA is expected to acquire Genzyme Corp. (GENZ) for about $19 billion in cash, plus possible additional payments in the future, in a deal that could be announced as soon as Wednesday.
The WSJ reports that Sanofi-Aventis SA is expected to acquire Genzyme Corp. (GENZ) for about $19 billion in cash, plus possible additional payments in the future, in a deal that could be announced as soon as Wednesday.
Copyright © 2024 Wall Street Pit | Contact Us | Advertise | Terms of Use | Privacy Policy
Leave a Reply